DOI:
10.1055/s-00000133
Gastroenterologie up2date
LinksClose Window
References
Bokemeyer C. et al.
KRAS status and efficacy of first-line treatment of patients with metastatic colorectal cancer (mCRC) with FOLFOX with or without cetuximab: The OPUS experience.
J Clin Oncol 2008; 26: Abstract 4000-
Search in:
We do not assume any responsibility for the contents of the web pages of other providers.